HPR232 Eurocover-CLL: Reimbursement and Accessibility for New Treatments in Relapsed/Refractory Chronic Lymphocytic Leukemia in Central and Eastern Europe
Dec 1, 2024, 00:00
10.1016/j.jval.2024.10.1656
https://www.valueinhealthjournal.com/article/S1098-3015(24)04519-4/fulltext
Title :
HPR232 Eurocover-CLL: Reimbursement and Accessibility for New Treatments in Relapsed/Refractory Chronic Lymphocytic Leukemia in Central and Eastern Europe
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)04519-4&doi=10.1016/j.jval.2024.10.1656
First page :
Section Title :
Open access? :
No
Section Order :
11119